Until recently, the UN was on track to meet its target of ending AIDS as a public health threat by 2030. But with the U.S. rapidly scaling back foreign aid contributions, the UN has released a new ...

While many channels of the drug are being plugged regularly by authorities, the crisis is worsening - more supply routes than what can be cracked down on ...

Psilocybin shows promise for extending lifespan and slowing aging by preserving telomeres, new studies reveal.

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

New data demonstrated that long-acting cabotegravir was preferable to daily dolutegravir/lamivudine in treatment-naive people living with HIV.

GSK has expanded its voluntary licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) for cabotegravir, allowing it to be produced by three generic drugmakers and supplied to ...

We’ve come a long way in treating HIV, the virus that can lead to AIDs. Just last month, the FDA approved a medication that is said to have the potential to end the HIV pandemic.

A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...

HIV/AIDS : Welcome to Medscape HIV/AIDS, where you can peruse the latest medical news, commentary from clinician experts, major conference coverage, full-text journal articles, and trending stories.

A German doctor has gone on trial in Berlin, accused of murdering 15 patients who were under palliative care. The man, who ...

He added that Fiji stands to lose over 50 percent of its current land-based economy even with just 1.5 degrees Celsius of ...